In Silico Integration of Transcriptome and Interactome Predicts an ETP-ALL-Specific Transcriptional Footprint that Decodes its Developmental Propensity

Early T precursor acute lymphoblastic leukemia (ETP-ALL) exhibits poor clinical outcomes and high relapse rates following conventional chemotherapeutic protocols. Extensive developmental flexibility of the multipotent ETP-ALL blasts with considerable intra-population heterogeneity in terms of immunophenotype and prognostic parameters might be a target for novel therapeutic interventions. Using a public gene expression dataset (GSE28703) from NCBI GEO DataSets with 12 ETP-ALL and 40 non-ETP-ALL samples, such heterogeneity was found to be reflected in their transcriptome as well. Hub genes were identified from the STRING-derived functional interaction network of genes showing differential expression between ETP-ALL and non-ETP-ALL as well as variable expression across ETP-ALL. Nine genes (KIT, HGF, NT5E, PROM1, CD33, ANPEP, CDH2, IL1B, and CXCL2) among the hubs were further validated as possible diagnostic ETP-ALL markers using another gene expression dataset (GSE78132) with 17 ETP-ALL and 27 non-ETP-ALL samples. Linear dimensionality reduction analysis with the expression levels of the hub genes in ETP-ALL revealed their divergent inclinations towards different hematopoietic lineages, proposing them as novel indicators of lineage specification in the incompletely differentiated ETP-ALL blasts. This further led to the formulation of a personalized lineage score calculation algorithm, which uncovered a considerable B-lineage-bias in a substantial fraction of ETP-ALL subjects from the GSE28703 and GSE78132 cohorts. In addition, STRING-derived physical interactome of the potential biomarkers displayed complete segregation of the B-lineage-skewed markers from other lineage-associated factors, highlighting their distinct functionality and possible druggability in ETP-ALL. A panel of these biomarkers might be useful in pinpointing the dominant lineage specification programmes in the ETP-ALL blasts on a personalized level, urging the development of novel lineage-directed precision therapies as well as repurposing of existing therapies against leukemia of different hematopoietic lineages; which might overcome the drawbacks of conventional chemotherapy.

[1]  P. Musto,et al.  Inside the biology of early T-cell precursor acute lymphoblastic leukemia: the perfect trick , 2021, Biomarker research.

[2]  Chun-fung Sin,et al.  Early T-Cell Precursor Acute Lymphoblastic Leukemia: Diagnosis, Updates in Molecular Pathogenesis, Management, and Novel Therapies , 2021, Frontiers in Oncology.

[3]  S. Barik,et al.  Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures , 2021, Cells.

[4]  F. Staal,et al.  The Route of Early T Cell Development: Crosstalk between Epigenetic and Transcription Factors , 2021, Cells.

[5]  N. Chandra,et al.  VB10, a new blood biomarker for differential diagnosis and recovery monitoring of acute viral and bacterial infections , 2021, EBioMedicine.

[6]  Kathleen M. Jagodnik,et al.  Gene Set Knowledge Discovery with Enrichr , 2021, Current protocols.

[7]  Guangwu Guo,et al.  Single cell RNA-seq reveals developmental plasticity with coexisting oncogenic and immune evasion programs in ETP-ALL. , 2020, Blood.

[8]  H. Hosokawa,et al.  How transcription factors drive choice of the T cell fate , 2020, Nature reviews. Immunology.

[9]  Jie Jin,et al.  Comparison of Early T-Cell Precursor and Non-ETP Subtypes Among 122 Chinese Adults With Acute Lymphoblastic Leukemia , 2020, Frontiers in Oncology.

[10]  Omar Castaneda Puglianini,et al.  Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving concepts , 2020, Therapeutic advances in hematology.

[11]  N. Viiala,et al.  Relapsed/Refractory ETP-ALL Successfully Treated With Venetoclax and Nelarabine as a Bridge to Allogeneic Stem Cell Transplant , 2020, HemaSphere.

[12]  Chi Zhang,et al.  Low LEF1 expression is a biomarker of early T-cell precursor, an aggressive subtype of T-cell lymphoblastic leukemia , 2020, PloS one.

[13]  Timothy L. Tickle,et al.  Integrated scRNA-Seq Identifies Human Postnatal Thymus Seeding Progenitors and Regulatory Dynamics of Differentiating Immature Thymocytes. , 2020, Immunity.

[14]  S. Mercadal,et al.  Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia , 2020, Haematologica.

[15]  B. Győrffy,et al.  ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti‐HER2 therapy using transcriptomic data of 3,104 breast cancer patients , 2019, International journal of cancer.

[16]  H. Tun,et al.  Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigens. , 2019, Cancer genetics.

[17]  K. Jacobs,et al.  Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia , 2019, HemaSphere.

[18]  Ellen V Rothenberg,et al.  Single-Cell Analysis Reveals Regulatory Gene Expression Dynamics Leading to Lineage Commitment in Early T Cell Development. , 2019, Cell systems.

[19]  J. Chu,et al.  Decitabine-containing G-CSF priming regimen overcomes resistance of primary mediastinal neoplasm from early T-cell precursors to conventional chemotherapy: a case report , 2019, OncoTargets and therapy.

[20]  H. Kantarjian,et al.  Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy , 2019, British journal of haematology.

[21]  L. Kumar,et al.  ETP‐ALL with aberrant B marker expression: Case series and a brief review of literature , 2019, International journal of laboratory hematology.

[22]  C. Cogle,et al.  Computational modeling of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) to identify personalized therapy using genomics. , 2019, Leukemia research.

[23]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[24]  Jan Gorodkin,et al.  Cytoscape stringApp: Network analysis and visualization of proteomics data , 2018, bioRxiv.

[25]  Frederik Otzen Bagger,et al.  BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles , 2018, Nucleic Acids Res..

[26]  Eun Woo Son,et al.  iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data , 2018, BMC Bioinformatics.

[27]  S. Barik,et al.  IL-4 and IL-13 Guide Early Thymic Progenitors To Mature toward Dendritic Cells , 2018, The Journal of Immunology.

[28]  H. Kantarjian,et al.  First report of clinical response to Venetoclax in Early T-cell Precursor Acute Lymphoblastic Leukemia. , 2018, JCO precision oncology.

[29]  Alice Giustacchini,et al.  Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic Progenitors. , 2018, Cancer cell.

[30]  Rosana Pelayo,et al.  T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies. , 2017, Blood reviews.

[31]  S. Barik,et al.  IL-4/IL-13 Signaling Inhibits the Potential of Early Thymic Progenitors To Commit to the T Cell Lineage , 2017, The Journal of Immunology.

[32]  Antonio Federico,et al.  Transcriptome Profiling in Human Diseases: New Advances and Perspectives , 2017, International journal of molecular sciences.

[33]  K. Spiekermann,et al.  Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL , 2016, Journal of Hematology & Oncology.

[34]  S. Hunger,et al.  The Functional Role of PRC2 in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) – Mechanisms and Opportunities , 2016, Front. Pediatr..

[35]  David S. Wishart,et al.  Heatmapper: web-enabled heat mapping for all , 2016, Nucleic Acids Res..

[36]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[37]  M. Konopleva,et al.  Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype. , 2016, Blood.

[38]  C. Mullighan,et al.  Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine. , 2015, Blood.

[39]  Rosane Minghim,et al.  InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams , 2015, BMC Bioinformatics.

[40]  Jaak Vilo,et al.  ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap , 2015, Nucleic Acids Res..

[41]  M. Loh,et al.  Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia. , 2015, Blood.

[42]  Chung-Yen Lin,et al.  cytoHubba: identifying hub objects and sub-networks from complex interactome , 2014, BMC Systems Biology.

[43]  M. Loh,et al.  T-Lymphoblastic Leukemia (T-ALL) Shows Excellent Outcome, Lack of Significance of the Early Thymic Precursor (ETP) Immunophenotype, and Validation of the Prognostic Value of End-Induction Minimal Residual Disease (MRD) in Children’s Oncology Group (COG) Study AALL0434 , 2014 .

[44]  R. Wade,et al.  Outcome for children and young people with Early T‐cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003 , 2014, British journal of haematology.

[45]  C. Mullighan,et al.  Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential , 2014, The Journal of experimental medicine.

[46]  R. Pandey,et al.  Immunophenotypic analysis of T‐acute lymphoblastic leukemia. A CD5‐based ETP‐ALL perspective of non‐ETP T‐ALL , 2014, European journal of haematology.

[47]  M. Tyers,et al.  BoxPlotR: a web tool for generation of box plots , 2014, Nature Methods.

[48]  A. Look,et al.  Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors , 2014, Haematologica.

[49]  S. Bohlander,et al.  Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations. , 2013, Blood.

[50]  Edward Y. Chen,et al.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.

[51]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[52]  C. Haymaker,et al.  Bone Marrow-Derived IL-13Rα1–Positive Thymic Progenitors Are Restricted to the Myeloid Lineage , 2012, The Journal of Immunology.

[53]  M. Witt,et al.  T‐cell acute lymphoblastic leukaemia: recent molecular biology findings , 2012, British journal of haematology.

[54]  D. Campana,et al.  Clinical significance of early T‐cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children’s Cancer Study Group Study L99‐15 , 2012, British journal of haematology.

[55]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[56]  I. Macaulay,et al.  The Earliest Thymic T Cell Progenitors Sustain B Cell and Myeloid Lineage Potentials , 2011, Nature Immunology.

[57]  Ralf Herwig,et al.  ConsensusPathDB: toward a more complete picture of cell biology , 2010, Nucleic Acids Res..

[58]  M. Loh,et al.  Patients with Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia (ALL) Have High Levels of Minimal Residual Disease (MRD) at the End of induction—A Children's Oncology Group (COG) Study. , 2009 .

[59]  Cheng Cheng,et al.  Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. , 2009, The Lancet. Oncology.

[60]  J. Taub.  Early T-cell precursor acute lymphoblastic leukaemia. , 2009, The Lancet. Oncology.

[61]  Ralf Herwig,et al.  ConsensusPathDB—a database for integrating human functional interaction networks , 2008, Nucleic Acids Res..

[62]  T. Ikawa,et al.  Adult T-cell progenitors retain myeloid potential , 2008, Nature.

[63]  A. Bhandoola,et al.  The earliest thymic progenitors for T cells possess myeloid lineage potential , 2008, Nature.

[64]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[65]  A Orfao,et al.  Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). , 1995, Leukemia.

[66]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .